Mucormycosis - from the pathogens to the disease

被引:112
作者
Binder, U. [1 ]
Maurer, E. [1 ]
Lass-Floerl, C. [1 ]
机构
[1] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Tirol, Austria
关键词
Angioinvasion; iron overload; ketoacidosis; mucorales; mucormycosis; risk factors; zygomycetes; CUTANEOUS MUCORMYCOSIS; RHIZOPUS-ORYZAE; IN-VITRO; HEMATOLOGIC MALIGNANCY; ASPERGILLUS-FUMIGATUS; SAKSENAEA-VASIFORMIS; PATTERN-RECOGNITION; ANTIFUNGAL THERAPY; IRON; ZYGOMYCOSIS;
D O I
10.1111/1469-0691.12566
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mucormycosis is an emerging fungal infection worldwide, with devastating disease symptoms and diverse clinical manifestations. The most important underlying risk factors are immunosuppression, poorly controlled diabetes, iron overload and major trauma. The aetiological agents involved in the disease have been re-classified due to changes in taxonomy and nomenclature, which also led to appropriately naming the disease mucormycosis'. This article shortly explains the new nomenclature, clinical manifestations and risk factors and focuses on putative virulence traits associated with mucormycosis, mainly in the group of diabetic ketoacidotic patients.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 77 条
[51]   Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia [J].
Oren, H .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (05) :770-771
[52]   Epidemiology and Clinical Manifestations of Mucormycosis [J].
Petrikkos, George ;
Skiada, Anna ;
Lortholary, Olivier ;
Roilides, Emmanuel ;
Walsh, Thomas J. ;
Kontoyiannis, Dimitrios P. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S23-S34
[53]   Zygomycosis in Immunocompromised non-Haematological Patients [J].
Petrikkos, George ;
Drogari-Apiranthitou, Miranda .
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2011, 3 (01)
[54]   Mucormycosis after scorpion sting: case report [J].
Pourahmad, Morteza ;
Sepidkar, Abdolali ;
Farokhnia, Mohmmad H. ;
Tadayon, Seyed M. K. ;
Salehi, Hassan ;
Zabetian, Hassan .
MYCOSES, 2013, 56 (05) :589-591
[55]   Healthcare-Associated Mucormycosis [J].
Rammaert, Blandine ;
Lanternier, Fanny ;
Zahar, Jean-Ralph ;
Dannaoui, Eric ;
Bougnoux, Marie-Elisabeth ;
Lecuit, Marc ;
Lortholary, Olivier .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S44-S54
[56]   Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis [J].
Reed, Caitlin ;
Ibrahim, Ashraf ;
Edwards, John E., Jr. ;
Walot, Irwin ;
Spellberg, Brad .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) :3968-3969
[57]   Epidemiology and outcome of zygomycosis: A review of 929 reported cases [J].
Roden, MM ;
Zaoutis, TE ;
Buchanan, WL ;
Knudsen, TA ;
Sarkisova, TA ;
Schaufele, RL ;
Sein, M ;
Sein, T ;
Chiou, CC ;
Chu, JH ;
Kontoyiannis, DP ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (05) :634-653
[58]   Host Defenses Against Zygomycetes [J].
Roilides, Emmanuel ;
Kontoyiannis, Dimitrios P. ;
Walsh, Thomas J. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S61-S66
[59]   Invasive cutaneous infection caused by Apophysomyces elegans associated with a spider bite [J].
Saravia-Flores, Marcos ;
Guaran, Dennya M. ;
Argueta, Victor .
MYCOSES, 2010, 53 (03) :259-261
[60]   Disseminated zygomycosis due to Mycocladus corymbifera with cutaneous and cerebral involvement [J].
Schofield, Clare ;
Stern, Alexander ;
Jevtic, Andrew .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 (01) :E8-E11